Alexion Pharmaceuticals, Inc. (ALXN) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported Q2 EPS of $1.12, $0.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $512.5 million versus the consensus estimate of $509.54 million.
For earnings history and earnings-related data on Alexion Pharmaceuticals, Inc. (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
- American International Group (AIG) PT Raised to $89 at Piper Sandler
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
